Financials

  • Market Capitalization 121.64 M
  • Employee 5
  • Founded 2005
  • CEO N/A
  • Website www.neonc.com
  • Headquarter Delaware, United States
  • FIGI BBG01KPDB522
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.58
Rapporto prezzo/fatturato
4 011.7

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3851
ENGN
enGene Therapeutics Inc. - Common Stock
1.83 USD-4.19%+2.23%+1.10%-78.21%122.59 M USD
3853
TLSA
Tiziana Life Sciences Ltd - Common Shares
1.01 USD-6.48%-11.40%+6.32%-43.26%121.71 M USD
3856
PMN
ProMIS Neurosciences Inc. - Common Shares
13.47 USD-3.72%-6.13%-3.51%+2394.44%120.79 M USD
3860
GNLX
Genelux Corporation - Common Stock
2.66 USD-7.64%-1.48%-7.96%-19.39%120.35 M USD